CARDIEX LIMITED - Announcements

6.25%

3.0¢

Market Cap $16.50M

Technology Scientific & Technical Instruments

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

CDX	Trading Halt	PRICE SENSITIVE	19/04/18	430.92KB	Share
CDX	AtCor Announces First Steps in Major Strategic Repositioning	PRICE SENSITIVE	14/03/18	80.82KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/18	2.21MB	Share
CDX	AtCor's XCEL device clinically validated in 3rd party study	PRICE SENSITIVE	23/01/18	106.01KB	Share
CDX	AtCor and PhysioAge Systems announce supply agreement	PRICE SENSITIVE	11/01/18	149.46KB	Share
CDX	AtCor secures $1.0 million new pharmaceutical trial contract	PRICE SENSITIVE	15/12/17	115.97KB	Share
CDX	AtCor appoints Craig Cooper as CEO	PRICE SENSITIVE	30/11/17	105KB	Share
CDX	Chairman's address to 2017 AGM	PRICE SENSITIVE	30/11/17	77.14KB	Share
CDX	Tax Refund	PRICE SENSITIVE	30/10/17	128.71KB	Share
CDX	Security Purchase Plan	PRICE SENSITIVE	08/09/17	142.89KB	Share
CDX	Full Year Statutory Accounts	PRICE SENSITIVE	31/08/17	741.65KB	Share
CDX	Share Purchase Plan	PRICE SENSITIVE	29/08/17	115.47KB	Share
CDX	Share Placement	PRICE SENSITIVE	08/08/17	141.42KB	Share
CDX	Trading Halt	PRICE SENSITIVE	04/08/17	181.51KB	Share
CDX	AtCor restructures operations	PRICE SENSITIVE	02/08/17	235.55KB	Share
CDX	AtCor Signs New Agreement	PRICE SENSITIVE	31/07/17	244.69KB	Share
CDX	Secures $0.8 million new pharmaceutical trials contracts	PRICE SENSITIVE	12/07/17	228.83KB	Share
CDX	AtCor Signs New Network Health Systems Agreement	PRICE SENSITIVE	07/06/17	220.17KB	Share
CDX	Business update and Strategic Review	PRICE SENSITIVE	18/05/17	235.78KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/17	491.4KB	Share
CDX	AtCor Signs Local Health System Agreement	PRICE SENSITIVE	23/02/17	102.76KB	Share
CDX	Study Finds Central Aortic Waveform Improves HF Treatment	PRICE SENSITIVE	16/02/17	106.01KB	Share
CDX	Tax refund	PRICE SENSITIVE	14/02/17	128.7KB	Share
CDX	Positive Novartis drug trial using SphygmoCor XCEL	PRICE SENSITIVE	23/01/17	142.94KB	Share
CDX	AtCor completes share placement	PRICE SENSITIVE	16/11/16	81.47KB	Share
CDX	Trading Halt	PRICE SENSITIVE	14/11/16	217.88KB	Share
CDX	Leading research team highlights role of SphygmoCor	PRICE SENSITIVE	04/11/16	107.1KB	Share
CDX	FY2016 results-ACG.AX	PRICE SENSITIVE	30/08/16	127.91KB	Share
CDX	Full Year Statutory Accounts-ACG.AX	PRICE SENSITIVE	30/08/16	578.81KB	Share
CDX	Large national plan to reimburse SphygmoCor test-ACG.AX	PRICE SENSITIVE	07/07/16	90.09KB	Share
CDX	$0.6 million pharmaceutical trial extension-ACG.AX	PRICE SENSITIVE	29/06/16	37.01KB	Share
CDX	Tax refund	PRICE SENSITIVE	14/03/16	24.96KB	Share
CDX	Patent granted in USA	PRICE SENSITIVE	09/03/16	36.82KB	Share
CDX	FDA clearance for Oscar 2 with SphygmoCor inside	PRICE SENSITIVE	03/03/16	50.95KB	Share
CDX	CPT-1 Reimbursement Update	PRICE SENSITIVE	29/02/16	39KB	Share
CDX	Patent granted in Japan	PRICE SENSITIVE	17/02/16	36.79KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	12/02/16	285.08KB	Share
CDX	US$0.6m new pharmaceutical trial contract	PRICE SENSITIVE	05/02/16	39.54KB	Share
CDX	Market update	PRICE SENSITIVE	08/01/16	30.13KB	Share
CDX	AtCor and A&D sign multiyear distribution contract for Japan	PRICE SENSITIVE	16/12/15	50.87KB	Share
CDX	US Medicare payment for new category 1 code announced	PRICE SENSITIVE	02/11/15	30.54KB	Share
CDX	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	20/08/15	723.79KB	Share
CDX	Rights offer booklet	PRICE SENSITIVE	01/07/15	105.91KB	Share
CDX	Successful share placement and rights issue	PRICE SENSITIVE	17/06/15	33.54KB	Share
CDX	Trading Halt	PRICE SENSITIVE	15/06/15	64.29KB	Share
CDX	Expert panel guidelines for central waveform analysis	PRICE SENSITIVE	28/05/15	38.31KB	Share
CDX	CE Mark for Oscar 2 with SphygmoCor Inside	PRICE SENSITIVE	04/05/15	55.09KB	Share
CDX	AMA accepts recommendation for category 1 CPT code	PRICE SENSITIVE	10/03/15	50.31KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/15	279.99KB	Share
CDX	Tax refund	PRICE SENSITIVE	22/01/15	24.53KB	Share
CDX +OCP	Successful share placement	PRICE SENSITIVE	28/11/14	26.17KB	Share
CDX	Trading Halt	PRICE SENSITIVE	27/11/14	51.72KB	Share
CDX	SphygmoCor selected for US publicly funded study	PRICE SENSITIVE	07/10/14	26.13KB	Share
CDX	SphygmoCor selected for French Alzheimers trial	PRICE SENSITIVE	03/09/14	32.26KB	Share
CDX	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	28/08/14	1.16MB	Share
CDX	Market update	PRICE SENSITIVE	03/07/14	32.4KB	Share
CDX	AtCor and SunTech launch innovative ABPM for Central BP	PRICE SENSITIVE	18/06/14	48.99KB	Share
CDX	First SphygmoCor sales in China	PRICE SENSITIVE	02/06/14	29.56KB	Share
CDX	Patent grant in USA	PRICE SENSITIVE	16/04/14	35.76KB	Share
CDX	Study shows improved outcomes from SphygmoCor guided therapy	PRICE SENSITIVE	03/04/14	39.06KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/14	346.08KB	Share
CDX	SphygmoCor XCEL approved for sale in Canada	PRICE SENSITIVE	30/01/14	104.91KB	Share
CDX	SphygmoCor XCEL approved for sale in China	PRICE SENSITIVE	14/01/14	108.08KB	Share
CDX	Market update	PRICE SENSITIVE	09/01/14	157.53KB	Share
CDX	ASX Price Query & Response	PRICE SENSITIVE	12/11/13	172.08KB	Share
CDX	US$0.6 million new pharmaceutical trial contract	PRICE SENSITIVE	28/10/13	99.62KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/13	237.08KB	Share
CDX	Aust study demonstrates the benefits of measuring central BP	PRICE SENSITIVE	26/09/13	35.59KB	Share
CDX	SphygmoCor XCEL approved for sale in Mexico	PRICE SENSITIVE	04/09/13	33.36KB	Share
CDX	Preliminary Final Report & Annual Accounts	PRICE SENSITIVE	30/08/13	483.09KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	30/08/13	483.14KB	Share
CDX	SphygmoCor XCEL approved for sale in Republic of Korea	PRICE SENSITIVE	07/08/13	33.5KB	Share
CDX	Seminal study for central pressures in clinical practice	PRICE SENSITIVE	01/08/13	35.14KB	Share
CDX	AtCor to report full year maiden profit	PRICE SENSITIVE	22/07/13	43.88KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/13	176.9KB	Share
CDX	Patent granted in Europe	PRICE SENSITIVE	15/07/13	18.79KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/13	177.24KB	Share
CDX	New study strongly supports measurement of central pressures	PRICE SENSITIVE	19/04/13	21.51KB	Share
CDX	US$0.8million pharmaceutical trial contract expansion	PRICE SENSITIVE	25/02/13	18.56KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/13	800.84KB	Share
CDX	AtCor to report profit for H1 FY2013	PRICE SENSITIVE	31/01/13	44.22KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	22/01/13	177.18KB	Share
CDX	Tax refund	PRICE SENSITIVE	18/12/12	64.71KB	Share
CDX	US$350,000 order for publicly funded study	PRICE SENSITIVE	05/12/12	64.69KB	Share
CDX	SphygmoCor XCEL receives US FDA clearance	PRICE SENSITIVE	20/11/12	47.29KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	18/10/12	176.74KB	Share
CDX	US$3.2 million pharmaceutical trial contract	PRICE SENSITIVE	08/10/12	18.64KB	Share
CDX	Full Year Statutory Accounts	PRICE SENSITIVE	23/08/12	3.06MB	Share
CDX	US$1.1 million pharmaceutical contract	PRICE SENSITIVE	13/08/12	18.54KB	Share
CDX	Chairman's Address to Shareholders	PRICE SENSITIVE	08/08/12	65.4KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/12	177.16KB	Share
CDX	Business Update	PRICE SENSITIVE	04/07/12	65.52KB	Share
CDX	Success share placement	PRICE SENSITIVE	15/06/12	65.19KB	Share
CDX	Reinstatement to Official Quotation	PRICE SENSITIVE	15/06/12	23.48KB	Share
CDX	Suspension from Official Quotation	PRICE SENSITIVE	14/06/12	90.62KB	Share
CDX	Trading Halt	PRICE SENSITIVE	12/06/12	86.93KB	Share
CDX	AtCor to enter new market segment	PRICE SENSITIVE	07/06/12	67.08KB	Share
CDX	Acquisition of Alliance Partner SunTech by Halma plc	PRICE SENSITIVE	05/06/12	68.54KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/12	177.41KB	Share
CDX	New CPT code to be established	PRICE SENSITIVE	07/03/12	66.63KB	Share

CDX Trading Halt
19/04/18	PRICE SENSITIVE	430.92KB	Share
CDX AtCor Announces First Steps in Major Strategic Repositioning
14/03/18	PRICE SENSITIVE	80.82KB	Share
CDX Half Yearly Report and Accounts
28/02/18	PRICE SENSITIVE	2.21MB	Share
CDX AtCor's XCEL device clinically validated in 3rd party study
23/01/18	PRICE SENSITIVE	106.01KB	Share
CDX AtCor and PhysioAge Systems announce supply agreement
11/01/18	PRICE SENSITIVE	149.46KB	Share
CDX AtCor secures $1.0 million new pharmaceutical trial contract
15/12/17	PRICE SENSITIVE	115.97KB	Share
CDX AtCor appoints Craig Cooper as CEO
30/11/17	PRICE SENSITIVE	105KB	Share
CDX Chairman's address to 2017 AGM
30/11/17	PRICE SENSITIVE	77.14KB	Share
CDX Tax Refund
30/10/17	PRICE SENSITIVE	128.71KB	Share
CDX Security Purchase Plan
08/09/17	PRICE SENSITIVE	142.89KB	Share
CDX Full Year Statutory Accounts
31/08/17	PRICE SENSITIVE	741.65KB	Share
CDX Share Purchase Plan
29/08/17	PRICE SENSITIVE	115.47KB	Share
CDX Share Placement
08/08/17	PRICE SENSITIVE	141.42KB	Share
CDX Trading Halt
04/08/17	PRICE SENSITIVE	181.51KB	Share
CDX AtCor restructures operations
02/08/17	PRICE SENSITIVE	235.55KB	Share
CDX AtCor Signs New Agreement
31/07/17	PRICE SENSITIVE	244.69KB	Share
CDX Secures $0.8 million new pharmaceutical trials contracts
12/07/17	PRICE SENSITIVE	228.83KB	Share
CDX AtCor Signs New Network Health Systems Agreement
07/06/17	PRICE SENSITIVE	220.17KB	Share
CDX Business update and Strategic Review
18/05/17	PRICE SENSITIVE	235.78KB	Share
CDX Half Yearly Report and Accounts
24/02/17	PRICE SENSITIVE	491.4KB	Share
CDX AtCor Signs Local Health System Agreement
23/02/17	PRICE SENSITIVE	102.76KB	Share
CDX Study Finds Central Aortic Waveform Improves HF Treatment
16/02/17	PRICE SENSITIVE	106.01KB	Share
CDX Tax refund
14/02/17	PRICE SENSITIVE	128.7KB	Share
CDX Positive Novartis drug trial using SphygmoCor XCEL
23/01/17	PRICE SENSITIVE	142.94KB	Share
CDX AtCor completes share placement
16/11/16	PRICE SENSITIVE	81.47KB	Share
CDX Trading Halt
14/11/16	PRICE SENSITIVE	217.88KB	Share
CDX Leading research team highlights role of SphygmoCor
04/11/16	PRICE SENSITIVE	107.1KB	Share
CDX FY2016 results-ACG.AX
30/08/16	PRICE SENSITIVE	127.91KB	Share
CDX Full Year Statutory Accounts-ACG.AX
30/08/16	PRICE SENSITIVE	578.81KB	Share
CDX Large national plan to reimburse SphygmoCor test-ACG.AX
07/07/16	PRICE SENSITIVE	90.09KB	Share
CDX $0.6 million pharmaceutical trial extension-ACG.AX
29/06/16	PRICE SENSITIVE	37.01KB	Share
CDX Tax refund
14/03/16	PRICE SENSITIVE	24.96KB	Share
CDX Patent granted in USA
09/03/16	PRICE SENSITIVE	36.82KB	Share
CDX FDA clearance for Oscar 2 with SphygmoCor inside
03/03/16	PRICE SENSITIVE	50.95KB	Share
CDX CPT-1 Reimbursement Update
29/02/16	PRICE SENSITIVE	39KB	Share
CDX Patent granted in Japan
17/02/16	PRICE SENSITIVE	36.79KB	Share
CDX Half Yearly Report and Accounts
12/02/16	PRICE SENSITIVE	285.08KB	Share
CDX US$0.6m new pharmaceutical trial contract
05/02/16	PRICE SENSITIVE	39.54KB	Share
CDX Market update
08/01/16	PRICE SENSITIVE	30.13KB	Share
CDX AtCor and A&D sign multiyear distribution contract for Japan
16/12/15	PRICE SENSITIVE	50.87KB	Share
CDX US Medicare payment for new category 1 code announced
02/11/15	PRICE SENSITIVE	30.54KB	Share
CDX App 4E / Full Year Statutory Accounts
20/08/15	PRICE SENSITIVE	723.79KB	Share
CDX Rights offer booklet
01/07/15	PRICE SENSITIVE	105.91KB	Share
CDX Successful share placement and rights issue
17/06/15	PRICE SENSITIVE	33.54KB	Share
CDX Trading Halt
15/06/15	PRICE SENSITIVE	64.29KB	Share
CDX Expert panel guidelines for central waveform analysis
28/05/15	PRICE SENSITIVE	38.31KB	Share
CDX CE Mark for Oscar 2 with SphygmoCor Inside
04/05/15	PRICE SENSITIVE	55.09KB	Share
CDX AMA accepts recommendation for category 1 CPT code
10/03/15	PRICE SENSITIVE	50.31KB	Share
CDX Half Yearly Report and Accounts
23/02/15	PRICE SENSITIVE	279.99KB	Share
CDX Tax refund
22/01/15	PRICE SENSITIVE	24.53KB	Share
CDX +OCP Successful share placement
28/11/14	PRICE SENSITIVE	26.17KB	Share
CDX Trading Halt
27/11/14	PRICE SENSITIVE	51.72KB	Share
CDX SphygmoCor selected for US publicly funded study
07/10/14	PRICE SENSITIVE	26.13KB	Share
CDX SphygmoCor selected for French Alzheimers trial
03/09/14	PRICE SENSITIVE	32.26KB	Share
CDX App 4E / Full Year Statutory Accounts
28/08/14	PRICE SENSITIVE	1.16MB	Share
CDX Market update
03/07/14	PRICE SENSITIVE	32.4KB	Share
CDX AtCor and SunTech launch innovative ABPM for Central BP
18/06/14	PRICE SENSITIVE	48.99KB	Share
CDX First SphygmoCor sales in China
02/06/14	PRICE SENSITIVE	29.56KB	Share
CDX Patent grant in USA
16/04/14	PRICE SENSITIVE	35.76KB	Share
CDX Study shows improved outcomes from SphygmoCor guided therapy
03/04/14	PRICE SENSITIVE	39.06KB	Share
CDX Half Yearly Report and Accounts
20/02/14	PRICE SENSITIVE	346.08KB	Share
CDX SphygmoCor XCEL approved for sale in Canada
30/01/14	PRICE SENSITIVE	104.91KB	Share
CDX SphygmoCor XCEL approved for sale in China
14/01/14	PRICE SENSITIVE	108.08KB	Share
CDX Market update
09/01/14	PRICE SENSITIVE	157.53KB	Share
CDX ASX Price Query & Response
12/11/13	PRICE SENSITIVE	172.08KB	Share
CDX US$0.6 million new pharmaceutical trial contract
28/10/13	PRICE SENSITIVE	99.62KB	Share
CDX Appendix 4C - quarterly
23/10/13	PRICE SENSITIVE	237.08KB	Share
CDX Aust study demonstrates the benefits of measuring central BP
26/09/13	PRICE SENSITIVE	35.59KB	Share
CDX SphygmoCor XCEL approved for sale in Mexico
04/09/13	PRICE SENSITIVE	33.36KB	Share
CDX Preliminary Final Report & Annual Accounts
30/08/13	PRICE SENSITIVE	483.09KB	Share
CDX Half Yearly Report and Accounts
30/08/13	PRICE SENSITIVE	483.14KB	Share
CDX SphygmoCor XCEL approved for sale in Republic of Korea
07/08/13	PRICE SENSITIVE	33.5KB	Share
CDX Seminal study for central pressures in clinical practice
01/08/13	PRICE SENSITIVE	35.14KB	Share
CDX AtCor to report full year maiden profit
22/07/13	PRICE SENSITIVE	43.88KB	Share
CDX Appendix 4C - quarterly
22/07/13	PRICE SENSITIVE	176.9KB	Share
CDX Patent granted in Europe
15/07/13	PRICE SENSITIVE	18.79KB	Share
CDX Appendix 4C - quarterly
23/04/13	PRICE SENSITIVE	177.24KB	Share
CDX New study strongly supports measurement of central pressures
19/04/13	PRICE SENSITIVE	21.51KB	Share
CDX US$0.8million pharmaceutical trial contract expansion
25/02/13	PRICE SENSITIVE	18.56KB	Share
CDX Half Yearly Report and Accounts
21/02/13	PRICE SENSITIVE	800.84KB	Share
CDX AtCor to report profit for H1 FY2013
31/01/13	PRICE SENSITIVE	44.22KB	Share
CDX Appendix 4C - quarterly
22/01/13	PRICE SENSITIVE	177.18KB	Share
CDX Tax refund
18/12/12	PRICE SENSITIVE	64.71KB	Share
CDX US$350,000 order for publicly funded study
05/12/12	PRICE SENSITIVE	64.69KB	Share
CDX SphygmoCor XCEL receives US FDA clearance
20/11/12	PRICE SENSITIVE	47.29KB	Share
CDX Appendix 4C - quarterly
18/10/12	PRICE SENSITIVE	176.74KB	Share
CDX US$3.2 million pharmaceutical trial contract
08/10/12	PRICE SENSITIVE	18.64KB	Share
CDX Full Year Statutory Accounts
23/08/12	PRICE SENSITIVE	3.06MB	Share
CDX US$1.1 million pharmaceutical contract
13/08/12	PRICE SENSITIVE	18.54KB	Share
CDX Chairman's Address to Shareholders
08/08/12	PRICE SENSITIVE	65.4KB	Share
CDX Appendix 4C - quarterly
31/07/12	PRICE SENSITIVE	177.16KB	Share
CDX Business Update
04/07/12	PRICE SENSITIVE	65.52KB	Share
CDX Success share placement
15/06/12	PRICE SENSITIVE	65.19KB	Share
CDX Reinstatement to Official Quotation
15/06/12	PRICE SENSITIVE	23.48KB	Share
CDX Suspension from Official Quotation
14/06/12	PRICE SENSITIVE	90.62KB	Share
CDX Trading Halt
12/06/12	PRICE SENSITIVE	86.93KB	Share
CDX AtCor to enter new market segment
07/06/12	PRICE SENSITIVE	67.08KB	Share
CDX Acquisition of Alliance Partner SunTech by Halma plc
05/06/12	PRICE SENSITIVE	68.54KB	Share
CDX Appendix 4C - quarterly
24/04/12	PRICE SENSITIVE	177.41KB	Share
CDX New CPT code to be established
07/03/12	PRICE SENSITIVE	66.63KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.0¢		Change -0.002(6.25%)		Mkt cap ! $16.50M

Open	High	Low	Value	Volume
3.3¢	3.3¢	3.0¢	$23.07K	729.8K

Buyers (Bids)

No.	Vol.	Price($)
1	30000	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	30000	0.031
7	402143	0.030
2	275000	0.028
2	325000	0.027
2	320039	0.025

Price($)	Vol.	No.
0.033	100000	1
0.034	100000	1
0.036	71197	1
0.037	500000	1
0.038	580000	1

Last trade - 15.56pm 12/08/2025 (20 minute delay)

CDX (ASX) Chart

CARDIEX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories